NCOA3 and breast cancer: To test our hypothesis that chaperonin CCTs play a role in promoting the growth of ERα-positive breast cancer cells on harder substrates, we used bioinformatic analyses to screen ERα and ERα-related co-activators that contain polyglutamine-repeat domains, and identified AIB1 [22].